Sanofi Consumer Healthcare India Ltd vs Smruthi Organics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Sanofi Consumer Healthcare India Ltd is ₹ 4592 as of 05 May 15:30 . The P/E Ratio of Sanofi Consumer Healthcare India Ltd changed from 62.6 on December 2024 to 62.6 on December 2024 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Smruthi Organics Ltd changed from 14.9 on March 2021 to 0 on December 2024 . This represents a CAGR of -100.00% over 7 years The Market Cap of Sanofi Consumer Healthcare India Ltd changed from ₹ 11347 crore on December 2024 to ₹ 11347 crore on December 2024 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Smruthi Organics Ltd changed from ₹ 254.45 crore on March 2021 to ₹ 0 crore on December 2024 . This represents a CAGR of -100.00% over 7 years The revenue of Sanofi Consumer Healthcare India Ltd for the Jun '26 is ₹ 234.8 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the growth of 9.2233718E16% The revenue of Smruthi Organics Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 38.17 crore. This represent the decline of -100% The ebitda of Sanofi Consumer Healthcare India Ltd for the Jun '26 is ₹ 94.4 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the growth of 9.2233718E16% The ebitda of Smruthi Organics Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 4.75 crore. This represent the decline of -100% The net profit of Sanofi Consumer Healthcare India Ltd changed from ₹ 62.7 crore to ₹ 67.8 crore over 8 quarters. This represents a CAGR of 3.99% The net profit of Smruthi Organics Ltd changed from ₹ -0.92 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Sanofi Consumer Healthcare India Ltd changed from 6.06 % on December 2023 to 69.89 % on December 2024 . This represents a CAGR of 239.60% over 2 yearsThe Dividend Payout of Smruthi Organics Ltd changed from 20.08 % on March 2021 to 0 % on December 2024 . This represents a CAGR of -100.00% over 7 years .

About Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, as part of Sanofi's global strategy to establish a standalone Consumer Healthcare business.
This strategic move resulted in the demerger of the Consumer Healthcare business from Sanofi India Limited (SIL) into the Company through a Scheme of Arrangement, thereby creating a distinct legal entity.
The Scheme of Arrangement, which was sanctioned by the National Company Law Tribunal, Mumbai (NCLT) enabled the seamless transfer and vesting of all assets, liabilities, and operations of SIL to the Company. Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024.

About Smruthi Organics Ltd

Smruthi Organics Limited was incorporated in July, 1989 as a Private Limited Company and was subsequently converted into a Public Limited Company in February, 1995.
The Company was promoted by E Purushotham and Shankarrao R Myakal.
The Company is a manufacturer of Active Pharmaceutical Ingredient (API) products in the Anti - Diabetic, Anti - Hypertension and Anti - Infectives Therapeutic categories catering to both the Indian domestic as well as rest of the world (ROW) markets, with clients spanning across Asia, Americas, and Africa.
It has 2 manufacturing facilities in Solapur, India. The Company set up a plant at Solapur, Maharashtra, to manufacture bulk drugs like diloxanide furoate (inst. cap. : 24 tpa) and sulphadiazine (inst. cap. : 36 tpa).
It expanded its activities and product range in 1993-94 by manufacturing metronidazole benzoate, tinidazole, paracetamol and norfloxacin.

FAQs for the comparison of Sanofi Consumer Healthcare India Ltd and Smruthi Organics Ltd

Which company has a larger market capitalization, Sanofi Consumer Healthcare India Ltd or Smruthi Organics Ltd?

Market cap of Sanofi Consumer Healthcare India Ltd is 10,909 Cr while Market cap of Smruthi Organics Ltd is 136 Cr

What are the key factors driving the stock performance of Sanofi Consumer Healthcare India Ltd and Smruthi Organics Ltd?

The stock performance of Sanofi Consumer Healthcare India Ltd and Smruthi Organics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sanofi Consumer Healthcare India Ltd and Smruthi Organics Ltd?

As of May 5, 2026, the Sanofi Consumer Healthcare India Ltd stock price is INR ₹4737.15. On the other hand, Smruthi Organics Ltd stock price is INR ₹118.85.

How do dividend payouts of Sanofi Consumer Healthcare India Ltd and Smruthi Organics Ltd compare?

To compare the dividend payouts of Sanofi Consumer Healthcare India Ltd and Smruthi Organics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.